Home » Point Therapeutics to Sell 3.65 Million Shares
Point Therapeutics to Sell 3.65 Million Shares
Drug development firm Point Therapeutics said recently it plans to sell 3.65 million of its common shares at $4.50 each in a direct offering, primarily to institutional investors. Point Therapeutics shares fell 67 cents, or 12.6 percent, to $4.63 in morning trading on the Nasdaq. The company said SG Cowen & Co. acted as lead agent and sole book manager and RBC Capital Markets served as the co-agent for the offering.
Yahoo News (http://biz.yahoo.com/ap/050301/point_therapeutics_stock_offer_1.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May